Equity Overview
Price & Market Data
Price: $1.67
Daily Change: -$0.035 / 2.10%
Daily Range: $1.66 - $1.92
Market Cap: $65,859,072
Daily Volume: 49,882
Performance Metrics
1 Week: -2.06%
1 Month: -22.20%
3 Months: 75.26%
6 Months: -40.54%
1 Year: -60.73%
YTD: -44.87%
Company Details
Employees: 209
Sector: Health technology
Industry: Medical specialties
Country:
Details
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.